Format

Send to

Choose Destination
Ann Surg Oncol. 2012 Jun;19(6):1732-7. doi: 10.1245/s10434-012-2257-y. Epub 2012 Mar 17.

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.

Author information

1
Division of Surgical Oncology, Department of Surgery, Avon Comprehensive Breast Evaluation Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Abstract

PURPOSE AND METHODS:

Most patients who harbor a genetic mutation for hereditary breast cancer have not been identified, despite the availability of genetic testing. Developing an effective approach to the identification of high-risk individuals is the key to preventing and/or providing early diagnosis of cancer in this patient population. This educational review addresses these issues.

RESULTS AND DISCUSSION:

Using data available on the internet, and making assumptions regarding the types and results of genetic testing, we have estimated the number of mutation carriers in the country and the number who have been tested and identified as such. Overall, our ability to fund and more effectively manage carriers is weak. A technological solution is discussed.

PMID:
22427173
DOI:
10.1245/s10434-012-2257-y
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center